Drugs / AL-12182
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00069706 | Jul → Oct 2003 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-12182 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00069706 ↗ |
| Action | Activate | “Prostanoid FP receptor agonist” CHEMBL184999 ↗ |
| Modality | Small molecule | — CHEMBL184999 ↗ |
| Target | PTGFR | “Prostanoid FP receptor agonist” CHEMBL184999 ↗ |